Search Results - "L'Haridon, R.M."

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    IFN-tau: A novel subtype I IFN1. Structural characteristics, non-ubiquitous expression, structure-function relationships, a pregnancy hormonal embryonic signal and cross-species therapeutic potentialities by Martal, J.L., Chêne, N.M., Huynh, L.P., L'Haridon, R.M., Reinaud, P.B., Guillomot, M.W., Charlier, M.A., Charpigny, S.Y.

    Published in Biochimie (01-08-1998)
    “…IFN-tau (IFN-τ) constitutes a new class of type I IFN which is not virus-inducible, unlike IFN-α and IFN-β, but is constitutively produced by the trophectoderm…”
    Get full text
    Journal Article
  2. 2

    single intrauterine infusion of sustained recombinant ovine interfron-tau extends corpus luteum lifespan in cycle ewes by L'Haridon, R.M, Huynh, L, Assal, N.E, Martal, J

    Published in Theriogenology (1995)
    “…Delivery carriers were developed to permit sustained release of recombinant ovine tau-interferon (roIFN-tau) to increase corpus luteum (CL) lifespan in cyclic…”
    Get full text
    Journal Article
  3. 3

    A single intrauterine infusion of sustained recombinant ovine interferon-τ extends corpus luteum lifespan in cyclic ewes by L'Haridon, R.M., Huynh, L., Assal, N.E., Martal, J.

    Published in Theriogenology (15-04-1995)
    “…Delivery carriers were developped to permit sustained release of recombinant ovine tau-interferon (roIFN-τ) to increase corpus luteum (CL) lifespan in cyclic…”
    Get full text
    Journal Article
  4. 4

    A single intrauterine infusion of sustained recombinant ovine interferon-tau extends corpus luteum lifespan in cycle ewes by L'Haridon, R.M. (INRA, Hoyen Josas, France.), Huynh, L, Assal, N.E, Martal, J

    Published in Theriogenology (15-04-1995)
    “…Delivery carriers were developed to permit sustained release of recombinant ovine tau-interferon (roIFN-tau) to increase corpus luteum (CL) lifespan in cyclic…”
    Get full text
    Journal Article
  5. 5

    Production of monoclonal antibodies against Clostridium difficile cytotoxin using immunosorbent binding bioassay procedure by Depitre, C, L'Haridon, R M, Lyerly, D M, Barroso, L A, Wilkins, T D, Andremont, A, Corthier, G

    Published in Toxicon (Oxford) (01-02-1993)
    “…In the following study, a novel screening approach was used to develop monoclonal antibodies specific for toxin B of Clostridium difficile. The approach, which…”
    Get more information
    Journal Article